导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 81.05% | 9/1050 |
| 近一周 | -1.52% | 228/1104 |
| 近一月 | -9.06% | 992/1102 |
| 近一季 | 10.99% | 80/1092 |
| 近半年 | 61.68% | 9/1070 |
| 近一年 | 103.39% | 7/1018 |
| 近两年 | 254.80% | 31/926 |
| 近三年 | 192.52% | 27/834 |
| 成立以来 | 237.07% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
6.83% 91/1070 |
108.89% 19/1101 |
- - |
- - |
| 2025 | 45.04% 245/1065 |
3.57% 510/1014 |
4.54% 324/1038 |
35.16% 272/1050 |
-0.89% 490/1065 |
| 2024 | 14.37% 191/1011 |
-3.03% 476/960 |
-1.39% 400/983 |
9.72% 641/991 |
9.00% 69/1011 |
| 2023 | -6.90% 249/952 |
14.98% 53/880 |
-5.91% 574/895 |
-11.82% 674/915 |
-2.40% 261/952 |
| 2022 | -14.01% 152/867 |
-11.98% 145/773 |
15.93% 103/806 |
-12.64% 435/845 |
-3.53% 597/867 |
| 2021 | 16.06% 184/740 |
-10.78% 505/580 |
19.47% 168/659 |
9.49% 73/704 |
-0.56% 462/740 |
| 2020 | 46.52% 259/554 |
0.50% 152/419 |
25.46% 186/466 |
1.58% 405/517 |
14.39% 218/554 |
| 2019 | 57.26% 94/410 |
30.52% 352/1149 |
-5.15% 719/1231 |
19.26% 18/390 |
6.51% 295/410 |
| 2018 | - - |
- - |
- - |
- - |
-4.47% 51/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 华商改革创新股票A VS. 东吴新产业精选股票A(580008) |